USA Insider Trading Pulse — July 27, 2026
The July 27, 2026 insider trading pulse reveals a market characterized by starkly divergent management actions. While a few significant insider purchases signal strong conviction in specific names like **Jefferies Credit Partners BDC** and **Greenwich LifeSciences**, the dominant theme is a wave of high-value, pre-planned insider selling by top executives at major companies. Notable sales by the CEO of **United Therapeutics** ($1.45M) and the CFO of **Hancock Whitney** ($1.73M) create a bearish undercurrent, particularly in the financial sector. A significant cluster of insider selling is also observed at **Opus Genetics**, where four top executives sold shares simultaneously, raising a major red flag. The day was also heavy with neutral, routine equity awards and tax-withholding transactions, which provide little directional signal but confirm standard compensation practices. The most actionable intelligence lies in the contrast between the large, strategic insider buying and the coordinated selling events, pointing to specific opportunities and risks for investors.